Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Bayer and Ginkgo Bioworks will create new biotech company

Bayer
Bayer and Ginkgo Bioworks will create a new company focused on the plant microbiome

Sanofi and Axxam started collaboration focused on CNS diseases

sanofi
Axxam, an innovative Partner Research Organization (iPRO), announced the start of a research collaboration with Sanofi

Bioverativ and Bicycle Therapeutics will jointly work on blood disease therapies

blood
Bioverativ Inc and Bicycle Therapeutics Ltdtoday announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell disease

Takeda and Noile-Immune Biotech to collaborate on CAR-T cell therapy

takeda
Takeda Pharmaceutical Company Limited and Noile-Immune Biotech Inc. announced that they have entered into a collaboration to develop next generation chimeric antigen receptor T cell therapy (CAR-T)

Chinese biopharmaceutical company 3SBio aquired Canadian CDMO

biotechnologies
3SBio Inc., a leading Chinese biopharmaceutical company, announced that it has entered into an Asset Purchase Agreement with Canada-based biologics manufacturer Therapure Biopharma

European Investment Bank provides subsidization to Austrian biotech company

eib
The European Investment Bank will provide financing of EUR 25 million to the Austrian biotech company Apeiron Biologics AG

Cambrex expanded its US facility with a $3.2 million analytical lab

lab
Cambrex Corporation announced that it is expanding its High Point, North Carolina, facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory

Dutch CRO Viroclinics Biosciences was bought by Parcom Capital

virus
Parcom Capital, a leading mid-market private equity fund, has acquired the successful clinical research organisation Viroclinics Biosciences

Emerging research programme gets financing from Novo Nordisk

novo nordisk
The newly established research programme, ’Programme for Translational Hematology’, has just received DKK 100 million (€135000) in funding from the Novo Nordisk

ACF Bioservices accomplished the construction of cGMP-compliant facility

good laboratory practice
ACF Bioservices announces the completion of construction on its dedicated cGMP-compliant 3400 square foot facility for gene and cell therapy product testing

Avista Healthcare teams up with Envigo CRO

pre-clinical
Avista Healthcare Public Acquisition Corp., a publicly traded special purpose acquisition company, and Envigo International Holdings, Inc., a leading early stage non-clinical contract research organization

Ethris and AstraZeneca will collaborate on mRNA therapies

astrazeneca
Ethris GmbH, a leader in mRNA-based therapeutics, today announced a five-year strategic research collaboration with AstraZeneca and its global biologics research and development arm, MedImmune

Johnson & Johnson set up partnership with Indian Microbial Technology Institute

johnson&johnson
Johnson & Johnson Private Limited announced a new partnership with the Institute of Microbial Technology to unlock the potential of Indian science and help accelerate the discovery of innovative new treatments for tuberculosis

Wuxi Biologics and Harbin Gloria out-licensed cancer drug to Arcus Biosciences

drugs quality control
WuXi Biologic and its Chinese partner Harbin Gloria Pharmaceuticals Co Ltd, yesterday announced that an exclusive license to the anti-PD-1 antibody GLS-010 has been granted to Arcus Biosciences

Sihuan Pharmaceutical launched R&D centre in California

lab
Sihuan Pharmaceutical announced that the Group has recently set up its Research and Development Centre in the San Francisco Bay Area

Takeda and Shattuck Labs will develop next-generation immunotherapies

takeda
Takeda Pharmaceutical Company Limited and Shattuck Labs, Inc. announced that they have entered into a research collaboration to explore and develop checkpoint fusion proteins